KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Accounts Payables (2020 - 2025)

Historic Accounts Payables for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $1.1 billion.

  • Organon's Accounts Payables fell 164.84% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 164.84%. This contributed to the annual value of $1.2 billion for FY2024, which is 1225.27% down from last year.
  • As of Q3 2025, Organon's Accounts Payables stood at $1.1 billion, which was down 164.84% from $1.1 billion recorded in Q2 2025.
  • Over the past 5 years, Organon's Accounts Payables peaked at $1.8 billion during Q2 2021, and registered a low of $264.0 million during Q1 2021.
  • Over the past 5 years, Organon's median Accounts Payables value was $1.1 billion (recorded in 2024), while the average stood at $1.1 billion.
  • Its Accounts Payables has fluctuated over the past 5 years, first skyrocketed by 43359.07% in 2021, then crashed by 3855.35% in 2022.
  • Organon's Accounts Payables (Quarter) stood at $1.4 billion in 2021, then dropped by 18.09% to $1.1 billion in 2022, then rose by 16.08% to $1.3 billion in 2023, then dropped by 12.25% to $1.2 billion in 2024, then decreased by 6.85% to $1.1 billion in 2025.
  • Its Accounts Payables stands at $1.1 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $1.0 billion for Q1 2025.